Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help.

Ontiveros F, Wilson EB, Livingstone AM.

Immunology. 2011 Apr;132(4):549-58. doi: 10.1111/j.1365-2567.2010.03400.x. Epub 2011 Jan 24.

2.

Unravelling the mechanisms of help for CD8+ T cell responses.

Livingstone AM, Wilson EB, Ontiveros F, Wang JC.

Immunol Res. 2009 Dec;45(2-3):209-17. doi: 10.1007/s12026-009-8102-0. Epub 2009 Feb 18. Review.

PMID:
19224140
3.

Breaking tolerance to tumors with dendritic cell-based immunotherapy.

Mende I, Engleman EG.

Ann N Y Acad Sci. 2005 Nov;1058:96-104. Review.

PMID:
16394129
4.

Dendritic cells as stimulator cells of MHC class I-restricted immune responses.

Elbe A, Stingl G.

Adv Exp Med Biol. 1995;378:341-5. Review.

PMID:
8526088
5.

Killer dendritic cells and their potential for cancer immunotherapy.

Larmonier N, Fraszczak J, Lakomy D, Bonnotte B, Katsanis E.

Cancer Immunol Immunother. 2010 Jan;59(1):1-11. doi: 10.1007/s00262-009-0736-1. Epub 2009 Jul 18. Review.

PMID:
19618185
6.

Regulation of effector and memory T-cell functions by type I interferon.

Huber JP, Farrar JD.

Immunology. 2011 Apr;132(4):466-74. doi: 10.1111/j.1365-2567.2011.03412.x. Epub 2011 Feb 14. Review.

7.

Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens.

Burlingham WJ, Goulmy E.

Hum Immunol. 2008 Nov;69(11):728-31. doi: 10.1016/j.humimm.2008.08.289. Epub 2008 Sep 21. Review.

8.

Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination.

Oth T, Vanderlocht J, Van Elssen CH, Bos GM, Germeraad WT.

Mediators Inflamm. 2016;2016:5740373. doi: 10.1155/2016/5740373. Epub 2016 Feb 11. Review.

9.

Natural killer T (NKT) cell subsets in chlamydial infections.

Yang X.

Adv Exp Med Biol. 2007;601:243-6. Review.

PMID:
17713011
10.

Regulation of immune responses by prostaglandin E2.

Kalinski P.

J Immunol. 2012 Jan 1;188(1):21-8. doi: 10.4049/jimmunol.1101029. Review.

11.

The Role of Il-12 and Type I Interferon in Governing the Magnitude of CD8 T Cell Responses.

Starbeck-Miller GR, Harty JT.

Adv Exp Med Biol. 2015;850:31-41. doi: 10.1007/978-3-319-15774-0_3. Review.

PMID:
26324344
12.

Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response.

Schiavoni G, Mattei F, Gabriele L.

Front Immunol. 2013 Dec 25;4:483. doi: 10.3389/fimmu.2013.00483. Review.

13.

Perioperative IFN-alpha to avoid surgically induced immune suppression in colorectal cancer patients.

Oosterling SJ, van der Bij GJ, Mels AK, Beelen RH, Meijer S, van Egmond M, van Leeuwen PA.

Histol Histopathol. 2006 Jul;21(7):753-60. doi: 10.14670/HH-21.753. Review.

PMID:
16598674

Supplemental Content

Support Center